Serum IP-10 has also been found to be raised in patients with recent-onset T1D [48, 49] and Graves’ disease (hyperthyroidism) [46], and to correlate with increased disease activity in SLE [50] and AS [51]. The gene discussed is CXCL10; the disease is type 1 diabetes mellitus.